Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Aesica Recruits Operations Director in Formulated Products Business Unit

Published: Tuesday, February 05, 2013
Last Updated: Tuesday, February 05, 2013
Bookmark and Share
Aesica tasks Jarrett Palmer with running growing global manufacturing operations.

Aesica has appointed Jarrett Palmer as Operations Director of its formulated products business unit business.

Palmer has accumulated over 15 years’ experience in senior leadership positions and has managed facilities for global CMOs including Catalent Pharma Solutions and Piramal Healthcare.

Based at Aesica headquarters in Newcastle (UK), Palmer will report to Chris Gowland , Managing Director of Formulated Products.

Operations at the Queenborough facility (UK) and recently acquired sites in Europe - including Monheim and Zwickau (Germany) and Pianezza (Italy) - will be managed by Palmer who will coordinate operational activities around the company’s commercial scale manufacturing, packaging and distribution activities.

Pivotal to this new role is the continued sustainable growth of Aesica, which includes continuous improvement to drive manufacturing efficiency and managing growing demand for potent manufacturing from the company’s UK base.

“We are delighted to have Jarrett Palmer join Aesica as Operations Director. He brings significant experience with a long and established track record of managing sites for global CMOs. Jarrett’s role is central to the maintenance of high standards at our FDA approved commercial scale manufacturing sites. He will be critical to the acquisition process and will support senior management in identifying global acquisition targets and transitioning new sites in line with our exacting efficiency and quality standards”, commented Chris Gowland Managing Director of Formulated Products at Aesica.

“Aesica is one of the most exciting names in contract manufacturing at the moment”, added Palmer on his decision to join the company. “It has big plans for growth which will significantly increase its global footprint and its manufacturing and packaging capacity at commercial scale, which is what the market has a great demand for. The prospect of being at the heart of this dynamic business is what attracted me to Aesica. My goal is to ensure that at every step, we optimize our internal infrastructure so that our customers enjoy responsiveness and efficiency in all interaction with us.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Aesica Honoured with Prestigious Award
The CDMO secures the accolade for a sixth time through its talented personnel.
Monday, April 11, 2016
Aesica Adds Development Capability at Queenborough
Product life cycle services expanded including for high potent and controlled drugs.
Tuesday, April 05, 2016
The New Aesica Development Centre
Strategic relocation of development and clinical manufacturing services from Nottingham to Queenborough is now complete.
Wednesday, January 20, 2016
Aesica on Recruitment Drive at Queenborough Site
Aesica Pharmaceuticals has announced that it is actively recruiting for more skilled personnel at Queenborough ahead of the launch of its new development centre at the site.
Thursday, January 14, 2016
Bespak and Aesica Unveil New Single Source Supply Chain Solution
Supply chain solution for drug delivery device and pharmaceutical manufacturing services.
Friday, November 13, 2015
Aesica Introduces New Service Model with One CDMO
The company’s solution radically simplifies supply chain management – optimizing efficiency, improving performance and bringing products to market faster.
Wednesday, October 21, 2015
Aesica Launches New Brand Identity
Official launch to the market is planned for 13th October.
Tuesday, October 13, 2015
Aesica Secures Continuing FDA Approval of its Bulk Manufacture and Packaging Sites
FDA inspection results means Aesica will continue to grow its manufacturing and packaging services for pharmaceutical products for the US market.
Tuesday, February 03, 2015
Aesica Appoints VP, Business Development and Business Development Director
Appointment of Detlef Behrens and Sven Wrabletz for finished dose to drive service in Europe and achieve further growth.
Friday, October 31, 2014
Aesica Appoints New Product Release Manager
Company announces appointment of Adam Burgess.
Wednesday, August 20, 2014
Aesica Zwickau Marks 20th Anniversary
Continued growth and expansion of Company’s encapsulation services business.
Saturday, July 19, 2014
Aesica Recruits New Business Development Manager
Appointment of Nadine K. Reuter to aid sales drive across German, Austrian and Swiss Markets.
Thursday, July 03, 2014
Aesica Collaborates with QAD to Meet CFDA’s Shortened Serialization Deadline
The new system was implemented within three months.
Saturday, June 28, 2014
Aesica Successfully Introduces Serialization Services at Italian Site
Initiates commercial production of two product lines for the Chinese market.
Thursday, April 17, 2014
Aesica Led Consortium Wins Technology Strategy Board Grant
Funding secured for the consortium’s project to investigate an industrial biotechnology process to enable improved manufacture of an API.
Tuesday, April 08, 2014
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Epigenetics and Neural Cell Death
Researchers demonstrate how deregulation of an epigenetic mechanism active in early neurogenesis phases triggers neural cell death.
Ebola-Affected Countries Receive NIH Support
The National Institutes of Health has established a new program to further research capacity to study Ebola and other epidemics.
Immunotherapy Technique Holds Promise for Curing Food Allergies
Scientists develop immunotherapy technique that almost eliminating allergic response and anaphylactic response in food-allergic mice.
Skin Patch to Treat Peanut Allergy
NIH-funded study suggests peanut protein patch is a safe and convenient method of treatment.
Molecular Origins of Dust Mite Allergy Discovered
Scientists have identified molecules of house dust mites that are targeted by the immune system of children, developing allergic rhinitis and asthma.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos